SCHEMBL7733942

SCHEMBL7733942

O=C(Nc1ccccc1I)C1CCCCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 1/20 0.67
▸ HDAC3 O15379 1/20 0.67
▸ HDAC1 Q13547 1/20 0.67
▸ HDAC2 Q92769 1/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ HPGD P15428 2/20 0.60
▸ ALDH1A1 P00352 3/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ LMNA P02545 1/20 0.56
▸ TSHR P16473 1/20 0.55
▸ NPC1 O15118 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ PTPN1 P18031 1/20 0.51
▸ P2RX7 Q99572 2/20 0.51
▸ GAA P10253 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ MAOB P27338 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28019517 0.91 GAA (0.55) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL28256535 0.88 CETP (0.77) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL28258088 0.88 CETP (0.77) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL12323604 0.88 CETP (0.77) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL19423434 0.81 CETP (0.69) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL28734434 0.81 CETP (0.69) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL6825065 0.80 P2RX7 (0.72) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL13703413 0.80 HDAC3 (0.71) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL13212284 0.80 CETP (1.00) CETPHDAC3HDAC1HDAC2SMN1; SMN2
SCHEMBL4223097 0.80 HDAC1 (1.00) CETPHDAC3HDAC1HDAC2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399614-B1 TREATING NEUROMUSCULAR DYSFUNCTION OF LOWER URINARY TRACT VIA PERIPHERAL OR CENTRAL NERVOUS SYSTEM; SEROTONIN RECEPTOR ANTAGONIST RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 2002-06-04 — — US disclosed
Send feedback